Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction
Authors not yet confirmed · 2019 · Zhurnal Organicheskoi Khimii. 55(11):1781–1788
What does this source report?
Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
- Population and setting
- Preclinical research; no human efficacy established
- Evidence type
- Analytical / composition study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Chemistry and preclinical observations do not establish human efficacy or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Source identity and selected abstract or text passages checked; complete methods not appraised.
Recorded source-check date: 2026-10-03. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Author unconfirmed. Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction Zhurnal Organicheskoi Khimii. 55(11):1781–1788 2019.
Molekul research summary: https://molekul.io/research/adk-adaptogens-v-2019. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Bromantane
An adamantane-derived small molecule, also known as Ladasten. The expanded archive connects clinical asthenia studies, operator experiments and preclinical mechanisms, with model-specific limitations and safety findings.
Chlodantane
N-(adamantan-2-yl)-4-chlorobenzamide, an experimental benzamide from the Russian adamantane programme. Its amide linkage distinguishes it from Bromantane’s arylamine.
Camphane chlorobenzamide
An experimental camphane-based structural analogue of Chlodantane. The cage framework differs from adamantane; this is a chemical candidate, not an established treatment.